Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06677112 · ClinicalTrials.gov registry record · NA

MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer

A NA study of Endometrial Cancer, sponsored by Rachel Miller.

Recruiting
Registry status
NA
Development phase
625
Enrollment target
1
Study location

NCT06677112 is a NA study of Endometrial Cancer that is actively recruiting participants, run by Rachel Miller. The registered enrollment target is 625 participants, above the 521-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06677112, a NA study of Endometrial Cancer, is actively recruiting participants, sponsored by Rachel Miller.

RECRUITING
Registry status
NA
Development phase
625 participants
Enrollment target
1
Study location

Study Summary

This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging. This study will gather information to help determine the best way to evaluate lymph nodes during surgery for endometrial cancer.

Conditions Studied

Interventions

  • PROCEDURE Selective surgical staging
  • PROCEDURE REFLEX

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 625 participants
Start Date 2025-03-17
Est. Completion 2030-01
Phase NA

Sponsor

Rachel Miller

6 total trials

What the Registry Record Tells You About NCT06677112

The ClinicalTrials.gov registry entry for NCT06677112 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 625 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 521-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (20% higher). The listed sponsor is Rachel Miller, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Selective surgical staging is the first listed.

NCT06677112 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06677112 about?

NCT06677112 is a clinical study titled "MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer". This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging. This study will gather information to help determine the best way to evaluate lymph nodes during surgery for endometrial cancer.

What is the current status of trial NCT06677112?

This trial is currently recruiting. It is a NA study. The enrollment target is 625 participants. The study started on 2025-03-17. Estimated completion is 2030-01.

What conditions does trial NCT06677112 study?

This clinical trial studies the following conditions: Endometrial Cancer.

What interventions are being tested in trial NCT06677112?

The interventions under investigation include: Selective surgical staging (PROCEDURE), REFLEX (PROCEDURE).

Who is sponsoring clinical trial NCT06677112?

This trial is sponsored by Rachel Miller, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06677112 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.